PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930057
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930057
Next-Generation Sequencing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
Growth Factors of next-generation sequencing (NGS) Market
The global next-generation sequencing (NGS) market was valued at USD 10.44 billion in 2025 and is projected to reach USD 11.79 billion in 2026, eventually growing to USD 38.34 billion by 2034, representing a CAGR of 15.88% during the forecast period. North America dominated the market in 2025 with a 56.01% share, driven by advanced research infrastructure, significant R&D investments, strong adoption of genomics in clinical and research applications, and the presence of leading players like Illumina Inc., Thermo Fisher Scientific Inc., and PacBio.
Next-generation sequencing is a revolutionary technology that enables high-throughput, scalable, and rapid DNA sequencing, transforming genomics research and clinical diagnostics. Its applications span genetic testing, non-invasive prenatal testing, oncology, infectious disease monitoring, and personalized medicine. The COVID-19 pandemic accelerated NGS adoption as the technology was used to study, monitor, and sequence the SARS-CoV-2 virus, boosting research activities and investments in vaccine development.
Key Market Drivers
Diversified Applications in Diagnostics and Research: The decreasing costs of NGS and its high accuracy have expanded its applications in diagnostics, including cancer screening, reproductive health, genetic disorder detection, and companion diagnostics. For example, Thermo Fisher Scientific and Bayer collaborated in March 2024 to develop NGS-based companion diagnostic assays, supporting clinical pipelines.
Technological Advancements and Product Innovation: Continuous innovation in instruments and consumables has enhanced sequencing speed, accuracy, and data analysis. In June 2022, PerkinElmer launched the BioQule NGS System, an automated benchtop solution, while Illumina introduced Connected Insights, a cloud-based software for clinical NGS data analysis in March 2023. These advancements increase accessibility, efficiency, and adoption across research and clinical applications.
Government Initiatives and Genome Projects: Large-scale genome projects, such as the Genome India Project, Personalized Medicine Program (France), and Saudi Human Genome Program, have accelerated NGS adoption. Governments globally are funding genomic research to enhance disease diagnosis, personalized medicine, and biotechnology development.
Market Restraints
The growth of the NGS market faces challenges such as shortage of skilled personnel in developing nations, high investment requirements, and data storage limitations due to the massive volume of sequencing data generated. Additionally, emerging regions may lack sufficient infrastructure to fully leverage NGS technologies, restraining adoption.
Market Segmentation
By Type: The market is segmented into products and services. The products segment dominated the market in 2026 with 86.10% share, including instruments and consumables, due to high usage volume, continuous product launches, and availability. Services, including sequencing as a service, are projected to grow steadily as outsourcing increases.
By Technology: Sequencing technologies include Sequencing by Synthesis (SBS), nanopore sequencing, Ion semiconductor sequencing, and others. SBS held 68.41% share in 2026, led by Illumina's strong product portfolio. Nanopore sequencing is projected to grow rapidly due to portability and long-read capabilities.
By Application: The market is segmented into clinical and research & applied. Clinical applications dominated in 2026 with 51.96% share, driven by oncology, cardiovascular, genetic disorder diagnostics, and reproductive health. Research applications are expected to grow due to large-scale projects and technological adoption.
By End-User: Pharmaceutical & biotechnology companies accounted for 48.00% share in 2026, driven by research collaborations, drug discovery, and NGS adoption in development pipelines. Academic and research institutes are also increasing adoption due to government research funding and genome projects.
Regional Insights
North America generated USD 5.85 billion in 2025 and is projected to reach USD 6.18 billion by 2026, maintaining dominance due to strong research funding and advanced infrastructure. Asia Pacific is expected to witness the highest CAGR, driven by initiatives like the Genome India Project and rapid adoption of genomic medicine in China and Japan. Europe benefits from strong healthcare infrastructure and government support for genomics research. Latin America and the Middle East & Africa are projected to witness moderate growth, supported by partnerships and capacity expansion in genomics.
Competitive Landscape
The NGS market is highly consolidated, led by Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., QIAGEN, PacBio, Oxford Nanopore Technologies, PerkinElmer, and BGI. Key strategies include product innovation, collaborations, capacity expansion, and strategic partnerships. For instance, Illumina and HaploX collaborated in 2023 to provide locally manufactured sequencing instruments in China.
Conclusion
The global NGS market is projected to experience substantial growth from 2025 to 2034, driven by declining sequencing costs, expanded clinical and research applications, genome projects, technological innovation, and government support. North America remains the largest market, while Asia Pacific is expected to grow at the fastest rate. Dominance in products, SBS technology, clinical applications, and pharmaceutical & biotechnology end-users is expected to continue. Strategic initiatives by major players, along with advancements in sequencing platforms, will drive the market to reach USD 38.34 billion by 2034, enabling improved genomic research, diagnostics, and personalized healthcare worldwide.
Segmentation By Type
- Products
- Instruments
- Consumables
- Services
By Technology
- Sequencing By Synthesis (SBS)
- Nanopore Sequencing
- ION Semiconductor Sequencing
- Others
By Application
- Research & Applied
- Clinical
- Cardiovascular
- Oncology
- Genetic Diseases
- Reproductive Health
By End-User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
By Region
- North America (By Type, Technology, Application, End-User, and Country)
- U.S.
- Canada
- Europe (By Type, Technology, Application, End-User, and Country/ Sub-Region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (By Type, Technology, Application, End-User, and Country/ Sub-Region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of the Asia Pacific
- Latin America (By Type, Technology, Application, End-User, and Country/ Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Type, Technology, Application, End-User, and Country/ Sub-Region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Market Scope
- 1.2. Market Segmentation
- 1.3. Market Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Diseases, By Key Countries, 2025
- 4.2. Overview: Regulatory Scenario & Reimbursement Scenario, By Key Countries/Region
- 4.3. New Product Launches, By Key Players
- 4.4. Key Industry Developments, By Key Players
- 4.5. Overview: Technological Advancements in Next-generation Sequencing
- 4.6. Impact of COVID-19 on the Market
5. Global Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Products
- 5.1.1.1. Instruments
- 5.1.1.2. Consumables
- 5.1.2. Services
- 5.1.1. Products
- 5.2. Market Analysis, Insights and Forecast - By Technology
- 5.2.1. Sequencing By Synthesis (SBS)
- 5.2.2. Nanopore Sequencing
- 5.2.3. ION Semiconductor Sequencing
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - By Application
- 5.3.1. Research & Applied
- 5.3.2. Clinical
- 5.3.2.1. Cardiovascular
- 5.3.2.2. Oncology
- 5.3.2.3. Genetic Diseases
- 5.3.2.4. Reproductive Health
- 5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Pharmaceutical & Biotechnology Companies
- 5.4.2. Academic & Research Institutes
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Products
- 6.1.1.1. Instruments
- 6.1.1.2. Consumables
- 6.1.2. Services
- 6.1.1. Products
- 6.2. Market Analysis, Insights and Forecast - By Technology
- 6.2.1. Sequencing By Synthesis (SBS)
- 6.2.2. Nanopore Sequencing
- 6.2.3. ION Semiconductor Sequencing
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast - By Application
- 6.3.1. Research & Applied
- 6.3.2. Clinical
- 6.3.2.1. Cardiovascular
- 6.3.2.2. Oncology
- 6.3.2.3. Genetic Diseases
- 6.3.2.4. Reproductive Health
- 6.4. Market Analysis, Insights and Forecast - By End User
- 6.4.1. Pharmaceutical & Biotechnology Companies
- 6.4.2. Academic & Research Institutes
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Products
- 7.1.1.1. Instruments
- 7.1.1.2. Consumables
- 7.1.2. Services
- 7.1.1. Products
- 7.2. Market Analysis, Insights and Forecast - By Technology
- 7.2.1. Sequencing By Synthesis (SBS)
- 7.2.2. Nanopore Sequencing
- 7.2.3. ION Semiconductor Sequencing
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast - By Application
- 7.3.1. Research & Applied
- 7.3.2. Clinical
- 7.3.2.1. Cardiovascular
- 7.3.2.2. Oncology
- 7.3.2.3. Genetic Diseases
- 7.3.2.4. Reproductive Health
- 7.4. Market Analysis, Insights and Forecast - By End User
- 7.4.1. Pharmaceutical & Biotechnology Companies
- 7.4.2. Academic & Research Institutes
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.5.1. U.K
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Products
- 8.1.1.1. Instruments
- 8.1.1.2. Consumables
- 8.1.2. Services
- 8.1.1. Products
- 8.2. Market Analysis, Insights and Forecast - By Technology
- 8.2.1. Sequencing By Synthesis (SBS)
- 8.2.2. Nanopore Sequencing
- 8.2.3. ION Semiconductor Sequencing
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast - By Application
- 8.3.1. Research & Applied
- 8.3.2. Clinical
- 8.3.2.1. Cardiovascular
- 8.3.2.2. Oncology
- 8.3.2.3. Genetic Diseases
- 8.3.2.4. Reproductive Health
- 8.4. Market Analysis, Insights and Forecast - By End User
- 8.4.1. Pharmaceutical & Biotechnology Companies
- 8.4.2. Academic & Research Institutes
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Products
- 9.1.1.1. Instruments
- 9.1.1.2. Consumables
- 9.1.2. Services
- 9.1.1. Products
- 9.2. Market Analysis, Insights and Forecast - By Technology
- 9.2.1. Sequencing By Synthesis (SBS)
- 9.2.2. Nanopore Sequencing
- 9.2.3. ION Semiconductor Sequencing
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast - By Application
- 9.3.1. Research & Applied
- 9.3.2. Clinical
- 9.3.2.1. Cardiovascular
- 9.3.2.2. Oncology
- 9.3.2.3. Genetic Diseases
- 9.3.2.4. Reproductive Health
- 9.4. Market Analysis, Insights and Forecast - By End User
- 9.4.1. Pharmaceutical & Biotechnology Companies
- 9.4.2. Academic & Research Institutes
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Next-generation Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Products
- 10.1.1.1. Instruments
- 10.1.1.2. Consumables
- 10.1.2. Services
- 10.1.1. Products
- 10.2. Market Analysis, Insights and Forecast - By Technology
- 10.2.1. Sequencing By Synthesis (SBS)
- 10.2.2. Nanopore Sequencing
- 10.2.3. ION Semiconductor Sequencing
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast - By Application
- 10.3.1. Research & Applied
- 10.3.2. Clinical
- 10.3.2.1. Cardiovascular
- 10.3.2.2. Oncology
- 10.3.2.3. Genetic Diseases
- 10.3.2.4. Reproductive Health
- 10.4. Market Analysis, Insights and Forecast - By End User
- 10.4.1. Pharmaceutical & Biotechnology Companies
- 10.4.2. Academic & Research Institutes
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Illumina Inc.
- 11.2.1.1. Overview
- 11.2.1.2. Products & services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Thermo Fisher Scientific Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Products & services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. F. Hoffmann-La Roche Ltd.
- 11.2.3.1. Overview
- 11.2.3.2. Products & services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. QIAGEN
- 11.2.4.1. Overview
- 11.2.4.2. Products & services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. PacBio
- 11.2.5.1. Overview
- 11.2.5.2. Products & services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Oxford Nanopore Technologies
- 11.2.6.1. Overview
- 11.2.6.2. Products & services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Perkin Elmer, Inc.
- 11.2.7.1. Overview
- 11.2.7.2. Products & services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. BGI
- 11.2.8.1. Overview
- 11.2.8.2. Products & services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.1. Illumina Inc.
List of Tables
- Table 1: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 2: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 3: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 4: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 5: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
- Table 6: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 7: Global Next-generation Sequencing Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 8: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 9: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 10: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 11: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 12: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
- Table 13: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 14: North America Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 15: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 16: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 17: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 18: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 19: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
- Table 20: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 21: Europe Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 22: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 23: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 24: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 25: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 26: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
- Table 27: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 28: Asia Pacific Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 29: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 30: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 31: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 32: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 33: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
- Table 34: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 35: Latin America Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 36: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 37: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 38: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 39: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 40: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
- Table 41: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 42: Middle East & Africa Next-generation Sequencing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Next-generation Sequencing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Next-generation Sequencing Market Value Share (%), by Type, 2025 & 2034
- Figure 3: Global Next-generation Sequencing Market Value Share (%), by Technology, 2025 & 2034
- Figure 4: Global Next-generation Sequencing Market Value Share (%), by Application, 2025 & 2034
- Figure 5: Global Next-generation Sequencing Market Value Share (%), by End User, 2025 & 2034
- Figure 6: Global Next-generation Sequencing Market Value (USD billion), by Region, 2025 & 2034
- Figure 7: North America Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
- Figure 8: North America Next-generation Sequencing Market Value Share (%), by Type, 2025
- Figure 9: North America Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
- Figure 10: North America Next-generation Sequencing Market Value Share (%), by Technology, 2025
- Figure 11: North America Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
- Figure 12: North America Next-generation Sequencing Market Value Share (%), by Application, 2025
- Figure 13: North America Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
- Figure 14: North America Next-generation Sequencing Market Value Share (%), by End User, 2025
- Figure 15: North America Next-generation Sequencing Market Value (USD billion), By Country, 2025 & 2034
- Figure 16: North America Next-generation Sequencing Market Value Share (%), By Country, 2025
- Figure 17: Europe Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
- Figure 18: Europe Next-generation Sequencing Market Value Share (%), by Type, 2025
- Figure 19: Europe Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
- Figure 20: Europe Next-generation Sequencing Market Value Share (%), by Technology, 2025
- Figure 21: Europe Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
- Figure 22: Europe Next-generation Sequencing Market Value Share (%), by Application, 2025
- Figure 23: Europe Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
- Figure 24: Europe Next-generation Sequencing Market Value Share (%), by End User, 2025
- Figure 25: Europe Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 26: Europe Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 27: Asia Pacific Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
- Figure 28: Asia Pacific Next-generation Sequencing Market Value Share (%), by Type, 2025
- Figure 29: Asia Pacific Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
- Figure 30: Asia Pacific Next-generation Sequencing Market Value Share (%), by Technology, 2025
- Figure 31: Asia Pacific Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
- Figure 32: Asia Pacific Next-generation Sequencing Market Value Share (%), by Application, 2025
- Figure 33: Asia Pacific Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
- Figure 34: Asia Pacific Next-generation Sequencing Market Value Share (%), by End User, 2025
- Figure 35: Asia Pacific Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 36: Asia Pacific Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 37: Latin America Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
- Figure 38: Latin America Next-generation Sequencing Market Value Share (%), by Type, 2025
- Figure 39: Latin America Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
- Figure 40: Latin America Next-generation Sequencing Market Value Share (%), by Technology, 2025
- Figure 41: Latin America Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
- Figure 42: Latin America Next-generation Sequencing Market Value Share (%), by Application, 2025
- Figure 43: Latin America Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
- Figure 44: Latin America Next-generation Sequencing Market Value Share (%), by End User, 2025
- Figure 45: Latin America Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 46: Latin America Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 47: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by Type, 2025 & 2034
- Figure 48: Middle East & Africa Next-generation Sequencing Market Value Share (%), by Type, 2025
- Figure 49: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by Technology, 2025 & 2034
- Figure 50: Middle East & Africa Next-generation Sequencing Market Value Share (%), by Technology, 2025
- Figure 51: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by Application, 2025 & 2034
- Figure 52: Middle East & Africa Next-generation Sequencing Market Value Share (%), by Application, 2025
- Figure 53: Middle East & Africa Next-generation Sequencing Market Value (USD billion), by End User, 2025 & 2034
- Figure 54: Middle East & Africa Next-generation Sequencing Market Value Share (%), by End User, 2025
- Figure 55: Middle East & Africa Next-generation Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 56: Middle East & Africa Next-generation Sequencing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 57: Global Next-generation Sequencing Market Share (%), By Company, 2025
